Create issue ticket

4,907 Possible Causes for N, ligand

Show results in: Română

  • Influenza

    7), 600–800 IU/wk ( n 7), 1000–1200 IU/wk ( n 46), and 1400 IU/wk ( n 8).[ajcn.org] HA ligand binds the virus to the cell to bring about infection.[ncbi.nlm.nih.gov] Hayden FG 1 , Sugaya N 1 , Hirotsu N 1 , Lee N 1 , de Jong MD 1 , Hurt AC 1 , Ishida T 1 , Sekino H 1 , Yamada K 1 , Portsmouth S 1 , Kawaguchi K 1 , Shishido T 1 , Arai M[ncbi.nlm.nih.gov]

  • Osteoporosis

    Institutional studies: summary data for Analysis 1.1 Study ID Randomisation method Protector design Intervention n Intervention N Control n Control N Design effect applied[doi.org] […] levels of the following markers of bone turnover: Beta-Crosslaps, osteocalcin, bone alkaline phosphatase, osteoprotegerin and receptor activator for nuclear factor kappa-B ligand[ncbi.nlm.nih.gov] In recent years, denosumab, a human monoclonal antibody against receptor activator of nuclear factor κB ligand (RANKL), has become widely used as an anti-osteoclastic agent[ncbi.nlm.nih.gov]

  • Urinary Tract Infection

    RESULTS: In total, 797 females attending primary care networks in England ( n 246, 30.9% of cohort), Wales ( n 213, 26.7%), the Netherlands ( n 133, 16.7%), and Spain ( n[ncbi.nlm.nih.gov] […] infection Conflict of interest statement Conflict of interest statement: J.W.J. and S.J.H. are inventors on US patent US8937167 B2, which covers the use of mannoside-based FimH ligand[ncbi.nlm.nih.gov] (HA) UTI without blood infection (n   24) and strains isolated from patients with community-acquired (CA)-UTIs (n   29) were tested for their adhesion to, invasion and translocation[ncbi.nlm.nih.gov]

  • Dementia

    […] living (n 63, MD -0.50, 95% CI -1.79 to 0.79) and quality of life (n 63, MD 19.00, 95% CI -23.12 to 61.12).[ncbi.nlm.nih.gov] The authors show here that blocking PD-L1, a PD-1 ligand, is similarly effective, and that both treatments reversed cognitive deficiencies, and modified disease pathology[nature.com] Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity .[doi.org]

  • Pharyngitis

    In addition, 58.7% ( n 37), 73% ( n 46), and 69.8% ( n 44) of the isolates harboured the clfA , cna , and hla genes, respectively.[ncbi.nlm.nih.gov] […] correlations between emm-based typing schemes, clinical disease and surface adhesins; covalent bond formation mediated by GAS pili and other adhesins in binding to host ligands[ncbi.nlm.nih.gov] Results show significant improvements of symptoms and cytology in active group (A, n 10) vs. control group (B, n 10).[ncbi.nlm.nih.gov]

  • Skin Infection

    Most infections were due to closely related strains of CC152 (n 8) and CC15 (n 3), two distantly related ( 34 000 core single nucleotide polymorphisms) clonal complexes.[ncbi.nlm.nih.gov] […] adhesion assay analysis, and time-lapse microscopy, we found the patient's T lymphocytes to express normal levels of β1 and β2 integrins but to be highly adhesive to integrin ligands[ncbi.nlm.nih.gov] CD8( ) T-cell recruitment to skin is independent of CD4( ) T cells and interferon-γ, but requires the expression of E- and P-selectin ligands by CD8( ) T cells.[ncbi.nlm.nih.gov]

  • Streptococcal Infection

    The surgical group consisted of children with tonsillectomy or adenotonsillectomy (n 56). The remaining children were categorized as non-surgery (n 64).[ncbi.nlm.nih.gov] […] syndrome (mean age: 11.0 3.0 years; 10 males), and 15 normal adults (mean age: 28.7 7.9 years; 8 males) underwent dynamic PK PET imaging and binding potential, a measure of ligand-TSPO[ncbi.nlm.nih.gov] […] receptor antagonists (combination group, n   24).[ncbi.nlm.nih.gov]

  • Pneumonia

    […] analysis and N 2; OR carbapenem versus non-carbapenem 2.29, 95% CI 1.19 to 4.43 for clinically evaluable patients analysis).[ncbi.nlm.nih.gov] Furthermore, CC chemokine ligand (CCL) 16 was a functional target gene of miR-1247.[ncbi.nlm.nih.gov] […] to 1.36), length of stay in ICU (mean difference (MD) 0.65, 95% CI 0.07 to 1.23) or adverse events (N 2; OR monotherapy versus combination 0.93, 95% CI 0.68 to 1.26).[ncbi.nlm.nih.gov]

  • Endocrine Dysfunction

    They include subclinical hypothyroidism ( n 3), primary hypothyroidism ( n 1), Sick Euthyroid syndrome ( n 3), central hypothyroidism ( n 2), secondary hypogonadism ( n 3)[jfmpc.com] These include cytotoxic T lymphocyte antigen-4 inhibitors, programmed cell death 1 (PD-1) antibodies, and PD-ligand 1 (PD-L1) antibodies.[ncbi.nlm.nih.gov] Harvard Medical School in Boston, and colleagues retrospectively studied 164 patients with metastatic lung cancer treated with programmed cell death 1/programmed cell death 1 ligand[empr.com]

  • Infectious Mononucleosis

    n 1 or 12.5%; P 0.009), and smoking (n 13 or 68.4% vs. n 6 or 31.6%; P 0.013) were associated with severe IM onset.[ncbi.nlm.nih.gov] MAb 171 is an effective inhibitor of all CR2-ligand interactions ( 1 , 13 , 46 ).[dx.doi.org] 90) and controls (n 220).[ncbi.nlm.nih.gov]

Further symptoms